Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20
Tirzepatide (Mounjaro) has shown even stronger weight loss results, with an average weight loss of 15-20% in recent trials
NAD+ therapy restores the cellular fuel supply that powers DNA repair (via PARP enzymes), sirtuin activation (the longevity gene pathway), and mitochondrial energy production
Were not going to cut corners for profit
However, genome editing-induced Exe4 secretion in the liver led to sustained plasma Exe4 levels, highlighting its potential for long-term clinical benefits, such as improved treatment adherence and prevention of relapse
Mounjaro, containing the active ingredient tirzepatide, is an FDA-approved medication specifically designed for treating type 2 diabetes in adults
Souto-Carneiro M, Tth L, Behnisch R, Urbach K, Klika KD, Carvalho RA, et al
US$ 29.12
US$ 25.26
US$ 25.30
US$ 28.62
US$ 25.49
US$ 28.47
